Orionis Biosciences
Orionis Biosciences is a biotech company in Waltham, United States. It has raised $160.0M across 2 rounds, most recently a $105.0M Corporate Round in May 2025.
- Headquarters
- Waltham, Massachusetts
- Employees
- 11–50
- Website
- orionisbio.com
- Total Funding
- $160.0M
- Last Round
- $105.0M Corporate RoundMay 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
It lists 11–50 employees. It has raised $160.0M in total across 2 rounds, most recently a $105.0M Corporate Round in May 2025. Investors include Genentech, Cormorant Asset Management and Novartis Venture Fund.
Funding History
May 2025
Sign up to see all 2 events
Funding: Series C through Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/orionis-biosciences"><img src="https://indexed.vc/api/badge/company/orionis-biosciences" alt="Orionis Biosciences on Indexed.vc" width="260" height="76" /></a>

